drugset / Trial / NCT00761150

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

NCT00761150 ↗

Phase 3 Completed 308 enrolled AbbVie
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary purpose of the study was to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

Timeline

Start
2008-09
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-712 Unknown 2 unknown —

Indications